Hot High Dividend Companies To Invest In 2015

The European equity rebound continues and within the region the small cap stocks have been quietly performing very well. The WisdomTree Europe Small Cap Dividend ETF (NYSE: DFE) focuses on small cap stocks that pay high dividends.

The index that the ETF tracks is composed of the bottom 25 percent of stocks based on market capitalization in the WisdomTree Europe Dividend Index. The companies are then weighted based on annual cash dividend paid. The current yield on the ETF is 2.6 percent.

The ETF is heavily weighted in the U.K., Sweden, Italy, and Germany, with the four countries making up over 60 percent of the allocation. The four top sectors are the industrials, consumer discretionary, financials, and information technology. The ETF is fairly diversified with the top ten making up only 18 percent of the portfolio.

10 Best Gold Stocks To Watch For 2016: Powershares Water Resource Portfolio (PHO)

PowerShares Water Resources Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Palisades Water Index (the Index). The Palisades Water Index includes water companies drawn from sectors, which include water utilities, treatment, analytical and monitoring, infrastructure and distribution, water resource management, and conglomerate water companies. The Index includes companies that focus on the provision of potable water, the treatment of water and the technology and services that are directly related to water consumption. The Palisades Water Index was created by Hydrogen Ventures, LLC.

The Fund will normally invest at least 80% of its total assets in American depositary receipts (ADRs) and common stocks of companies in the water industry. For purposes of this 80% policy, a company will be considered to be in the water industry if at least 50% of its revenues come from water-related activities. The Fund will normally invest at least 90% of its total assets in ADRs and common stocks that comprise the Index. The Fund, using an indexing investment approach, attempts to replicate the performance of the Index. The Fund generally will invest in the stocks comprising the Index in proportion to their weightings in the Index. The Fund�� investment advisor is PowerShares Capital Management LLC.

Advisors' Opinion:

• [By Aaron Levitt]

  Given just how many different water stocks there are, investors may be better suited in a broad portfolio. With nearly $1 billion in assets, the PowerShares Water Resources (PHO) is the largest exchange-traded fund (ETF) that covers the sector.

Hot High Dividend Companies To Invest In 2015: Eurobank Ergasias SA (EUROB)

Eurobank Ergasias SA, formerly EFG Eurobank Ergasias SA, is a banking and financial services group located in Greece. It is organized into five segments: Retail, incorporating customer current accounts, savings, deposits and investment savings products, credit and debit cards, consumer loans, small business banking and mortgages; Corporate, incorporating direct debit facilities, current accounts, deposits, overdrafts, loan and other credit facilities, foreign currency and derivative products to corporate entities; Wealth Management, incorporating private banking services, including total wealth management, to medium and high net worth individuals, insurance, mutual fund and investment savings products, and institutional asset management; Global and Capital Markets, incorporating investment banking services including corporate finance, merger and acquisition and equity brokerage, as well as International. On December 27, 2013, it merged by absorption of the New TT Hellenic Postbank SA. Advisors' Opinion:

• [By Corinne Gretler]

  National Bank of Greece surged 24 percent and Eurobank Ergasias SA (EUROB) more than doubled. The lenders��planned merger has been postponed and not canceled, Bank of Greece Governor George Provopoulos said, after statements on April 8 that they will be recapitalized separately.

Hot High Dividend Companies To Invest In 2015: Echo Therapeutics Inc (ECTE)

Echo Therapeutics, Inc. (Echo), incorporated on September 10, 2007, is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both analyte extraction and needle-free drug delivery. The Company is developing its Symphony CGM System (Symphony) as a non-invasive, wireless continuous glucose monitoring (CGM) system for use in hospital critical care units and for people with diabetes. The Prelude SkinPrep System (Prelude), a component of its Symphony CGM System, allows for skin permeation that enables extraction of analytes such as glucose. Prelude�� platform skin preparation technology also allows for needle-free, transdermal drug delivery.

Symphony CGM System

The Symphony CGM System incorporates a Prelude skin preparation device, transdermal sensor, wireless transmitter and data display monitor. When the electro-chemical glucose sensor is placed on the prepared site, it uses glucose oxidase to generate a continuous current that is proportional to the concentration of blood glucose in the vessels beneath the epidermis. The signals are then wirelessly transmitted to a remote monitor. The monitor, calibrated periodically with a reference blood glucose measurement, converts the data to a glucose measurement based on the reference value. The monitor displays glucose readings and also contains customizable early-warning alarms for hypo- or hyperglycemia.

Prelude SkinPrep System

The Company is developing Prelude as a transdermal skin preparation device for Symphony to improve the access to the interstitial fluids and the flow of molecules across the protective membrane of the stratum corneum, the outmost protective layer of the skin. Prelude incorporates the Company's skin abrasion control technology into a hand-held device used to prepare a small area of the skin. The non-invasive sensor is applied to this prepared area in order to measure the in! terstitial glucose levels.

Specialty Pharmaceuticals

The Company�� specialty pharmaceuticals pipeline is based on itsAzone transdermal drug reformulation technology. AzoneTS is a nontoxic, nonirritating skin penetration that is intended to enable topical application of food and drug administration (FDA) -approved drugs, including pharmaceutical products that previously could only be administered systemically. Its advanced drug candidate is Durhalieve, an AzoneTS formulation of triamcinolone acetonide, medium potency corticosteroid approved by the FDA for treatment of corticosteroid-responsive dermatoses. AzoneTS increases lipid membrane fluidity in the stratum corneum layer of the skin, thereby decreasing resistance to topically applied therapeutics.

The Company competes with Roche, Johnson & Johnson, Bayer, Abbott Laboratories , DexCom, Inc., Medtronic, Inc., Edwards Lifesciences Corporation, Optiscan Biomedical Corp., Medtronic, Glysure, Glumetrics Inc., Maquet and A. Menarini Diagnostics S.r.l.

Advisors' Opinion:

• [By Roberto Pedone]

  Another under-$10 health care player that's quickly moving within range of triggering a major breakout trade is Echo Therapeutics (ECTE), which is a transdermal medical device company with skin permeation technology. This stock has been destroyed by the bears so far in 2013, with shares off huge by 70%.

  If you take a look at the chart for Echo Therapeutics, you'll notice that this stock has been uptrending strong for the last month, with shares moving higher from its low of $2.14 to its intraday high of $3.06 a share. During that uptrend, shares of ECTE have been consistently making higher lows and higher highs, which is bullish technical price action. That move has pushed shares of ECTE back above its 50-day moving average at $2.65 a share, and it's just starting to push ECTE into breakout territory, since the stock has cleared some key near-term overhead resistance levels at $2.98 to $2.99 a share. That move is quickly pushing shares of ECTE within range of triggering an even bigger breakout trade.

  Market players should now look for long-biased trades in ECTE if it manages to break out above some major near-term overhead resistance at $3.30 a share with high volume. Look for a sustained move or close above that level with volume that registers near or above its three-month average volume of 211,103 shares. If that breakout triggers soon, then ECTE will set up to re-test or possibly take out its next major overhead resistance levels at $4 to $4.50 a share, or possibly even $5 to $6 a share.

  Traders can look to buy ECTE off any weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $2.65 a share, or right below more near-term support at $2.50 a share. One can also buy ECTE off strength once it clears $3.30 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.

• [By Bryan Murphy]

  Truth be told, Echo Therapeutics Inc. (NASDAQ:ECTE) doesn't look like a particularly impressive stock right now. At $2.92 per share, ECTE is just trading right around where it was a few days ago, not to mention a few weeks ago. And, without any real "news" from the company in months, it's tough to think the market's going to be getting excited about the stock anytime soon. When you take a closer look at Echo Therapeutics though, a few subtle-but-compelling clues start to appear.

Hot High Dividend Companies To Invest In 2015: Rowan Companies Inc.(RDC)

Rowan Companies, Inc. provides onshore and offshore oil and gas contract drilling services in the United States and internationally. The company offers its contract drilling services through its fleet of 28 self-elevating mobile offshore drilling platforms and 30 deep-well land drilling rigs. The company was founded in 1923 and is headquartered in Houston, Texas.

Advisors' Opinion:

• [By Dimitra DeFotis]

  Among energy stocks rising today: Producers of gas and gas liquids were higherm, including Devon (DVN) and�Consol Energy (CNX) rose about 2% each, while drillers�Nabors Industries (NBR) and�Rowan Companies (RDC) jumped more than 3% apiece. Oilfield services names Halliburton (HAL) and Baker Hughes (BHI) each rose nearly 2%.

• [By Ben Levisohn]

  The past six months have been unkind to offshore drillers like Noble (NE), Ensco (ESV), Rowan (RDC) and Transocean (RIG). That doesn’t mean it’s time to buy, however.

• [By Ben Levisohn]

  A bad year for offshore drillers is likely to get worse–and Morgan Stanley says even market favorite Rowan (RDC) could get hit. It recommends yield plays, including Seadrill (SDRL).

• [By Ben Levisohn]

  In fact, it’s a good day for offshore drillers all around, as Atwood Oceanics (ATW) has jumped 2.3% to $40.80, Rowan (RDC) has climbed 2.1% to $22.923 and Transocean (RIG) has advanced 0.7% to $28.98 and Noble (NE) is up 1.1% at $19.72.

Hot High Dividend Companies To Invest In 2015: Saes Getters SpA (SG&A)

SAES Getters SpA is an Italy-based company primarily engaged in the production of getters and metal dispensers. The Company structures its business into three main units: Industrial Applications, which includes getters and metal dispensers used in light sources and electron vacuum devices, getters for microelectronic and micromechanical systems, pumps for vacuum systems, getters for solar collectors, products for thermal insulation, and gas purifier systems; Shape Memory Alloys, which includes shape memory alloy semi-finished products, components and devices for medical and industrial applications, and Information Displays, which includes getters and metal dispensers for liquid crystal displays, and barium getters for cathode ray tubes. Additionally, through the Business Development Unit, the Company produces dryers and getters for organic light-emitting diode (OLED), sealants for solar panels and energy storage getter devices. Advisors' Opinion:

• [By GURUFOCUS]

  For investors, Qualcomm understand the benefits of cloud services. It seems there are numerous questions unresolved. Over the last decade, pharmaceutical companies have been aggregating years of research and development data into medical databases, initiating overhauls of its R&D and selling, general and administrative (SG&A) segments for Pharma. A company willing to build their capabilities, and open to a new view of value will likely achieve better outcomes. Delivering support, personalization, scalability, speed and flexibility are attractive areas for growth.

• [By Jason Rivera]

  To help facilitate this destruction of value has been that Koss has bought back a lot of its shares as the company has been overvalued. The below quote is from its most recent annual report.
  In April of 1995, the Board of Directors approved a stock repurchase program authorizing the Company to purchase from time to time up to $2,000,000 of its common stock for its own account. Subsequently, the Board of Directors periodically has approved increases in the stock repurchase program. As of June 30, 2012, the most recently approved increase was for additional purchases of $2,000,000, which occurred in October of 2006, for an aggregate maximum of $45,500,000, of which $43,360,247 had been expended through June 30, 2012 . No purchases were made during the year ended June 30, 2012. The Company intends to effect all stock purchases either on the open market or through privately negotiated transactions and intends to finance all stock purchases through its own cash flow or by borrowing for such purchases.As you can see from this page, most of KOSS' margins have dropped substantially since 2007. Especially of note is its operating margin, ROE and ROIC. Book value per share, cash flow per share, revenue and working capital have all dropped substantially as well. Normally when I have evaluated companies' cost of goods sold rising is what has caused the above metrics to drop, but that has stayed relatively stable over the years at KOSS. The culprit in this case is selling, general and administrative (SG&A) related expenses expressed below as a percentage of its sales. The following numbers were taken from Morningstar:

Hot High Dividend Companies To Invest In 2015: Atmos Energy Corporation(ATO)

Atmos Energy Corporation, together with its subsidiaries, engages primarily in the distribution, transmission, and storage of natural gas in the United States. The company operates in four segments: Natural Gas Distribution; Regulated Transmission and Storage; Natural Gas Marketing; and Pipeline, Storage, and Other. The Natural Gas Distribution segment involves in regulated natural gas distribution business and related sales operations. It distributes natural gas through regulated sales and transportation arrangements to approximately 3 million residential, commercial, public authority, and industrial customers in 12 states located primarily in the southern United States. As of September 30, 2009, this segment owned approximately 70,879 miles of underground distribution and transmission mains. The Regulated Transmission and Storage segment transports natural gas for third parties and manages five underground storage reservoirs in Texas. It owned 5,950 miles of gas transmis sion and gathering lines. The Natural Gas Marketing segment provides various natural gas management and marketing services to municipalities, other local gas distribution companies, and industrial customers. The Pipeline, Storage, and Other segment offers natural gas gathering, transmission, and storage services. It owned 113 miles of gas transmission and gathering lines. Atmos Energy Corporation was founded in 1906 and is headquartered in Dallas, Texas.

Advisors' Opinion:

• [By David Dittman]

  This mini-selloff has brought many UF Portfolio Holdings below our recommended buy-under targets and back into play for new money, including long-term favorites Atmos Energy Inc (NYSE: ATO) and Duke Energy Corp (NYSE: DUK) as well as recent additions such as NextEra Energy Inc (NYSE: NEE).

• [By Marc Courtenay]

  Another lesser-known possibility is Atmos Energy (ATO), the $3.93 billion (market cap) company that engages in the distribution, transmission, and storage of natural gas in the United States. As of the last quarter of 2012, its year-over-year EPS growth was 17.5%.

• [By Marc Bastow]

  Natural gas distribution and storage company Atmos (ATO) raised its quarterly dividend 5.7% to 37 cents per share, payable on Dec. 9 to shareholders of record as of Nov. 25. The increase marks the 26th consecutive year Atmos has raised its annual dividend.
  ATO Dividend Yield: 3.26%